| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2003 | WO2003024488A3 Combination of a pde inhibitor and a leukotriene receptor antagonist |
| 09/04/2003 | WO2003024432A3 Device for transdermal administration for the treatment of urinary tract disorders |
| 09/04/2003 | WO2003020273A3 Pharmaceutical composition comprising gabapentin or an analogue thereof and an $g(a)-aminoamide and its analgesic use |
| 09/04/2003 | WO2003020265A3 Compositions comprising pectin and ascorbic acid |
| 09/04/2003 | WO2003018743A3 Emu-based formulations for wound treatment |
| 09/04/2003 | WO2003018002A3 Cyclopropyl and cyclobutyl epothilone analogs |
| 09/04/2003 | WO2003017926A3 Treatment for lupus erythematosus |
| 09/04/2003 | WO2003015760A8 Use of dmso in the treatment of neurodegenerative diseases caused by prions |
| 09/04/2003 | WO2003011860A3 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
| 09/04/2003 | WO2003009808A3 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 09/04/2003 | WO2003005967A3 Dual release levodopa ethyl ester and decarboxylase in controlled release core |
| 09/04/2003 | WO2002097395A3 P-cadherin as a target for anti-cancer therapy |
| 09/04/2003 | WO2002093164A3 Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 09/04/2003 | WO2002088106A3 Cysteine protease inhibitors |
| 09/04/2003 | WO2002083858A8 Methods to inhibit viral replication |
| 09/04/2003 | WO2002079465A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
| 09/04/2003 | WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/04/2003 | WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 09/04/2003 | WO2002068387A8 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/04/2003 | WO2002068058A3 Dapd combination therapy with imdph inhibitors such as ribavirin or mycophenolic acid |
| 09/04/2003 | WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 09/04/2003 | WO2002055016A3 INHIBITION OF NF-λB BY TRITERPENE COMPOSITIONS |
| 09/04/2003 | WO2002052002A3 Immunomodulatory polynucleotides and methods of using the same |
| 09/04/2003 | WO2002049647A3 Novel therapeutic use of a thienylcyclohexylamine derivative |
| 09/04/2003 | WO2002049501A3 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 09/04/2003 | WO2002045708A3 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 09/04/2003 | WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 09/04/2003 | WO2002015892A3 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors |
| 09/04/2003 | WO2002009760A9 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 09/04/2003 | WO2002003977A3 Combinations of statins, estrogenic agents and optionally estrogens |
| 09/04/2003 | WO2002002097A3 Methods for treating seizure disorders by inhibiting mapk pathway activation with nitriles |
| 09/04/2003 | WO2001086002A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 09/04/2003 | WO2001081622A3 Diagnosis of diseases associated with dna repair |
| 09/04/2003 | WO2001076451A3 Diagnosis of diseases associated with metabolism |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 09/04/2003 | WO2000067776A9 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 09/04/2003 | US20030167525 Desaturase genes and uses thereof |
| 09/04/2003 | US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences |
| 09/04/2003 | US20030167261 Small-footprint applicative query interpreter method, system and program product |
| 09/04/2003 | US20030167033 Systems and methods for photodynamic therapy |
| 09/04/2003 | US20030167006 Ultrasound contrast using halogenated xanthenes |
| 09/04/2003 | US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 09/04/2003 | US20030166937 Fine particle size; anticoagulant |
| 09/04/2003 | US20030166935 Spiroazabicyclic heterocyclic compounds |
| 09/04/2003 | US20030166928 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents |
| 09/04/2003 | US20030166927 1,5-Benzothiazepines and their use as hypolipidaemics |
| 09/04/2003 | US20030166922 Antibiotics; therapy for antibiotic resistant infections |
| 09/04/2003 | US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents |
| 09/04/2003 | US20030166897 Diagnosis, therapy cancer; transgenic animal |
| 09/04/2003 | US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders |
| 09/04/2003 | US20030166883 Genetic engineering; drug screening |
| 09/04/2003 | US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration |
| 09/04/2003 | US20030166867 Fibrin nanoparticles and uses thereof |
| 09/04/2003 | US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound |
| 09/04/2003 | US20030166732 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity |
| 09/04/2003 | US20030166731 Method of treating hair loss using diphenylether derivatives |
| 09/04/2003 | US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines |
| 09/04/2003 | US20030166729 Use of prostaglandin derivatives of PGA, PGB, PGD, PGE and PGF, in which omega chain has been modified with common feature of containing a ring structure, for treatment of glaucoma or ocular hypertension |
| 09/04/2003 | US20030166728 Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer |
| 09/04/2003 | US20030166727 Antiinflammatory agents having analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic and anticancer activity |
| 09/04/2003 | US20030166725 Compounds active at the glucocorticoid receptor |
| 09/04/2003 | US20030166724 For treating or delaying progression or onset of obesity, hypercholesterolemia, atherosclerosis, depression, osteoporosis, hypothyroidism, non-toxic goiter, reduced bone mass, density or growth, eating disorders, cardiac arrhythmia |
| 09/04/2003 | US20030166723 Gamma-linolenic acid, di-homo-gamma-linolenic acid and derivatives |
| 09/04/2003 | US20030166722 4-hydroxy- alpha 1-(((6-(4-phenylbutoxy)-hexyl)-amino)-methyl)-1, 3-benzenedimethanol-4-phenylcinnamate salts for the tretment of asthma and chronic obstructive bronchitis |
| 09/04/2003 | US20030166720 Administering a therapeutic combination comprising a first amount of a fibric acid derivative and a second amount of a cholesteryl ester transfer protein inhibitor effective for treatment of hyperlipidemic conditions |
| 09/04/2003 | US20030166718 Dry powder granulated formulation of the compound racedotril useful for treating diarrhea |
| 09/04/2003 | US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases |
| 09/04/2003 | US20030166716 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 09/04/2003 | US20030166714 Nematicidal compositions and methods |
| 09/04/2003 | US20030166713 Photodynamid therapy |
| 09/04/2003 | US20030166712 Combinations of cholesteryl ester transfer protein inhibitors and HMG CoA reductase inhibitors for cardiovascular indications |
| 09/04/2003 | US20030166710 A cylic peroxide containing methyl carboxylic acid or ester; anticarcinogenic agent |
| 09/04/2003 | US20030166709 Use of an oily suspensions, containing the active ingredient in a solid phase a N-0923 (Rotigotine) for the treatment of diseases associated with dopamine metabolism, such as Parkinson's disease |
| 09/04/2003 | US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds |
| 09/04/2003 | US20030166706 Method of treating osteoarthritis |
| 09/04/2003 | US20030166705 Water-based liquid preparation |
| 09/04/2003 | US20030166704 Hydrolysis of (R)-5-(2-benzenesulphonylethyl)-3-N-methylpyrrolidin-2-ylmethyl)-1-acet o-indole using potassium carbonate in methanol/water to form eletriptan or hydrobromide salt |
| 09/04/2003 | US20030166703 Method of treatment |
| 09/04/2003 | US20030166702 Contacting carvedilol and ethyl acetate to form a solution, and cooling the solution whereby a precipitate is formed; hypotensive agent |
| 09/04/2003 | US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/04/2003 | US20030166700 Administering a substituted imidazoles to a mammal for the treatment of athroma progression and regression |
| 09/04/2003 | US20030166699 Use of angiotensin II receptor antagonists for treating acute myocardial infarction |
| 09/04/2003 | US20030166697 Divalent aromatic heterocyclic compounds useful in prevention or treatment of hyperlipidemia, arteriosclerosis, diabetes mellitus, hypertension, obesity, and the like |
| 09/04/2003 | US20030166696 Pramipexole for the treatment of HIV dementia |
| 09/04/2003 | US20030166694 Glycinamides |
| 09/04/2003 | US20030166692 Composition useful as anticancer drug and radiosensitizer |
| 09/04/2003 | US20030166691 Phenylalanine derivatives |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166689 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/04/2003 | US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 09/04/2003 | US20030166686 Beta3 adrenergic receptor agonist crystal forms, processes for the production thereof, and uses thereof |
| 09/04/2003 | US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer |
| 09/04/2003 | US20030166684 3-phenyl-furan-(5H)-2-one and dihydrofuran-2-one derivatives as antibacterial agents |
| 09/04/2003 | US20030166683 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 09/04/2003 | US20030166680 For treating serine protease or dual-serine protease mediated disorders |
| 09/04/2003 | US20030166676 Dichloroflosequinan; phosphodiesterase inhibitor |
| 09/04/2003 | US20030166674 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 09/04/2003 | US20030166673 Medicines for the prevention and treatment of neurodegenerative diseases |
| 09/04/2003 | US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation |